(Reuters) - The Trump Administration threw its support behind a public-private partnership with 11 drug companies to advance a new class of drugs that uses the body's immune system to fight cancer.


00


Reuters

Latest News

WashingtonPost: How Democrats can reward black women right now for their votes in Alabama and Virginia

FOX: Mental treatment ordered for man accused of cutting up wife

FOX: Walmart, Target dropping Mario Batali’s products from stores

FOX: Mom claims cryotherapy left her with severe burns, permanent scarring

FOX: Iraq hangs 38 ISIS, Al Qaeda militants in mass execution

FOX: Buyer beware: Think twice about pricey iPhone X, MacBook Pro models

FOX: Mom claims cryotherapy left her with severe burns, permanent scarring

ABC: Poland's lawmakers approve contentious new electoral rules

Los Angeles Times: 2018 New Year's Eve celebrations for $10,000 and up

Daily Mail: Harry and Meghan's wedding is the same day as FA Cup final

Daily Mail: Jessica Wright seen out with Strictly's Giovanni Pernice

Daily Mail: Two men jailed for a series of brutal assaults on gay men

Daily Mail: Poland's lawmakers approve contentious new electoral rules

Daily Mail: Man United's Bailly to have ankle surgery

Daily Mail: U.N. appalled at 30-year sentence for woman under El...

Reuters: Brazilian football boss Del Nero banned for 90 days: FIFA

Times of Israel: Last hurrah for Jewish Żelechow?

CNN: Royal wedding plans revealed

CNN: Watch Jeff Bezos' rocket launch a dummy into space

CNN: Jozy Altidore's MLS journey to the top

Los Angeles Times: 'Call Me by Your Name,' 'The Florida Project' lead Justin Chang's 12 best films of 2017

Los Angeles Times: The year reality and 'reality' fully intertwined

Los Angeles Times: Best architecture in 2017: In a tough year, plenty of highlights